Healthcare
June 13, 2018 / 5:23 AM / 8 months ago

BRIEF-Cellectis Publishes Methods to Improve Clinical Use of Chimeric Antigen Receptor T-Cell Therapy

1 Min Read

June 13(Reuters) - CELLECTIS SA:

* ANNOUNCED ON TUESDAY NOVEL METHODS TO IMPROVE THE CLINICAL USE OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY

* ANNOUNCED DEVELOPMENT OF AN ALL-IN-ONE CHIMERIC ANTIGEN RECEPTOR (CAR) ARCHITECTURE WITH AN EMBEDDED MULTI-FUNCTIONAL TAG FOR PURIFICATION, DETECTION AND ELIMINATION OF CAR T-CELLS

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below